Letter to the Editor

Toxic Epidermal Necrolysis Due to Administration of Celecoxib (Celebrex)

Authors: Pierre Giglio MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References 1. Friedman B, Orlet HK, Still JM, Law E. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J 2002; 95: 1213–1214.FriedmanB]]OrletHK]]StillJM]]LawEToxic epidermal necrolysis due to administration of celecoxib (Celebrex)South Med J2002951213 2. Gill S, Hermolin RH. Case report of a Stevens-Johnson type reaction to celecoxib. Can J Hosp Pharm 2001; 54( 2): 146(abstr).GillS]]HermolinRHCase report of a Stevens-Johnson type reaction to celecoxibCan J Hosp Pharm200154146 3. Ernst EJ, Egge JA. Celecoxib-induced erythema multiforme with glyburide cross-reactivity. Pharmacotherapy 2002; 22: 637–640.ErnstEJ]]EggeJACelecoxib-induced erythema multiforme with glyburide cross-reactivityPharmacotherapy200222637 4. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92–96.Bastuji-GarinS]]RzanyB]]SternRS]]ShearNH]]NaldiL]]RoujeauJCClinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformeArch Dermatol199312992